Caitlin John’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Caitlin John’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41.5K	Buy	262 +200	+323%	+$27K	0.02%	392
2026 Q1	$7.92K	Hold	62	–	–	﹤0.01%	554
2025 Q4	$7.56K	Hold	62	–	–	0.01%	578
2025 Q3	$6.21K	Buy	+62	New	+$5.58K	﹤0.01%	565
2025 Q1	–	Sell	-62	Closed	-$5.58K	–	817
2024 Q4	$5.58K	Hold	62	–	–	﹤0.01%	552
2024 Q3	$6.2K	Hold	62	–	–	﹤0.01%	543
2024 Q2	$5.75K	Hold	62	–	–	﹤0.01%	537
2024 Q1	$5.88K	Hold	62	–	–	﹤0.01%	541
2023 Q4	$5.54K	Buy	+62	New	+$4.6K	﹤0.01%	533

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Caitlin John's XBI Position: Q2 2026 in Review

Caitlin John increased its State Street SPDR S&P Biotech ETF (XBI) stake by 323% in Q2 2026, buying an estimated $27K and bringing the position to 262 shares worth $41.5K. The position accounts for 0.02% of the portfolio, ranked #392.

Caitlin John first reported a position in XBI in Q4 2023 and has held it in 9 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Caitlin John held 262 shares of State Street SPDR S&P Biotech ETF worth $41.5K as of Q2 2026.
Caitlin John bought 200 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $27K.
State Street SPDR S&P Biotech ETF made up 0.02% of Caitlin John's portfolio in Q2 2026, its #392 holding.
Caitlin John first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 9 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.